<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="162930">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01656096</url>
  </required_header>
  <id_info>
    <org_study_id>RSD-Leipzig</org_study_id>
    <nct_id>NCT01656096</nct_id>
  </id_info>
  <brief_title>Renal Sympathetic Denervation in Mild Refractory Hypertension</brief_title>
  <official_title>Renal Sympathetic Denervation in Patients With Mild Refractory Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Leipzig</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Leipzig</source>
  <oversight_info>
    <authority>Germany: Federal Institute for Drugs and Medical Devices</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the benefit of renal sympathetic denervation in
      patients with mild refractory hypertension
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2012</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in systolic blood pressure (ABPM mean value)</measure>
    <time_frame>6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Refractory Hypertension</condition>
  <arm_group>
    <arm_group_label>Renal sympathetic denervation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham procedure</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham procedure mimicking the renal sympathetic denervation procedure in the experimental arm</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Renal sympathetic denervation (Symplicity ablation catheter, Medtronic Inc. Minneapolis, Minnesota, USA)</intervention_name>
    <arm_group_label>Renal sympathetic denervation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham procedure</intervention_name>
    <arm_group_label>Sham procedure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Refractory hypertension: 3 or more antihypertensive agents of different classes
             (including a diuretic) at optimal dosage without change in the 4 weeks preceding
             randomization

          -  Systolic blood pressure of 135-149 and/or diastolic blood pressure of 90-94 mmHg
             (ABPM mean daytime values)

          -  No change in blood pressure medication within 6 months after randomization

          -  Age 18 to 75 years

          -  Informed consent

        Exclusion Criteria:

          -  Blood pressure outside range mentioned above

          -  Renal, aortic or pelvic anatomy unsuited for renal sympathetic denervation

          -  Estimated glomerular filtration rate &lt;45 mL/min/1.73 mÂ² (modification of diet in
             renal disease formula)

          -  Unstable angina pectoris

          -  Myocardial infarction within 6 months prior to randomization

          -  Planned surgery or cardiovascular intervention within 6 months after randomization

          -  Severe heart valve disease

          -  Severe comorbidities with limited life expectancy

          -  Pregnancy

          -  Participation in another trial
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steffen Desch, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Leipzig</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Steffen Desch, MD</last_name>
    <phone>0049341865</phone>
    <phone_ext>0</phone_ext>
    <email>stdesch@web.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Leipzig Heart Center</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Steffen Desch, MD</last_name>
      <phone>0049341865</phone>
      <phone_ext>0</phone_ext>
      <email>stdesch@web.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>August 5, 2013</lastchanged_date>
  <firstreceived_date>July 31, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Leipzig</investigator_affiliation>
    <investigator_full_name>Steffen Desch, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
